butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may well minimize sufentanil degrees and efficacy, perhaps precipitating withdrawal syndrome in people which have created Actual physical dependence to sufentanil